EP16.03: Treatment of viable Caesarean scar pregnancies with potassium chloride

Caesarean scar pregnancies (CSP) develop in the scar of the previous Caesarean section. These pregnancies carry several risks which if left untreated, may lead to maternal morbidities and mortality. There is a worldwide increase incidence of CSP due to assisted reproductive technologies and increase rate of Caesarean sections. Direct injection of potassium chloride (KCL) intracardiac has been used as a treatment of viable CSPs. All CSPs diagnosed by 2D ultrasound and treated with KCL in our institute were included and analysed. Data has been analysed by using descriptive statistics and inferential statistic via IBM SPSS® version 20. Continuous variables were checked for normality distribution and expressed as Mean (minimum – maximum) for non-parametric variables. Categorical variables were expressed as frequencies (n) and percentage of occurrence (%). Out of total 24 CSPs, 17 were treated only with KCL. All pregnancies were conceived spontaneously diagnosed by 2D transvaginal ultrasound. Mean maternal age, BMI and parity at diagnosis was 36, 31 and 3 respectively. Women had history of 2 – 5 previous CSs with minimum duration from previous surgery of 2.7 and maximum 5 years. In all cases, the access to fetal cardiac region was achieved and, in all cases, successful asystole was achieved. There were no immediate or long-term complications. KCL should be considered as an option for successful treatment of CSP. Patients with multiple CSs should be counselled about the risk of development of CSP. Early diagnosis leads to early management that results in decrease of maternal morbidities and mortality.